| 2016 | 2017 | 2018 | 2019 | 2020 | χ2 | P |
---|---|---|---|---|---|---|---|
MSM | |||||||
 Initially positive individuals positive | 5.5 | 5.3 | 4.7 | 4.4 | 4.1 | 743.46 | 0.000 |
 Individuals who took the confirmatory test | 88.2 | 88.1 | 89.6 | 88.5 | 79.8 | 605.63 | < 0.001 |
 Those retested positive and went through the treatment | – | 84.4 | 90.1 | 92.2 | 93.6 | 517.43 | < 0.001 |
FSW | |||||||
 Initially positive individuals positive | 0.2 | 0.5 | 0.2 | 0.3 | 0.4 | 155.22 | < 0.001 |
 Individuals who took the confirmatory test | 76.1 | 50.8 | 70.4 | 66.0 | 29.1 | 169.54 | < 0.001 |
 Those retested positive and went through the treatment | – | 84.0 | 82.4 | 87.4 | 99.0 | 16.55 | 0.001 |
DU | |||||||
 Initially positive individuals positive | 0.5 | 0.6 | 0.4 | 0.4 | 0.4 | 16.98 | 0.002 |
 Individuals who took the confirmatory test | 81.1 | 73.7 | 71.0 | 72.5 | 56.0 | 23.49 | < 0.001 |
 Those retested positive and went through the treatment | – | 72.5 | 82.3 | 97.7 | 95.4 | 27.58 | < 0.001 |